CLINICAL_TRIALS
trial_result
· 2018-06-27
Clinical Trial Update: STA-9090(Ganetespib) in Metastatic Ocular Melanoma [Phase 2]
Summary
Phase 2 trial of ganetespib (STA-9090) in metastatic ocular melanoma has been completed with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dana-Farber Cancer Institute | Conditions: Ocular Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2018-06-27